MicroCapClub

Ian Cassel gives the opening keynote at Planet MicroCap Las Vegas 2026 Powered by MicroCapClub. Not part of the MicroCapClub community? Join Us https://microcapclub.com/join-now/Planet Microcap hosts the highest quality microcap in-person events in North America. The mission is to bring the best microcap investors, companies, and allocators together to gather, connect, and grow. https://planetmicrocap.comDisclaimer: All content on this channel is for discussion, education, entertainment, and illustrative purposes only and SHOULD NOT be construed as professional financial advice, solicitation, or recommendation to buy or sell any securities, notwithstanding anything stated on this channel. There are risks associated with investing in securities. Loss of principal is possible. Past performance is not a predictor of future investment performance. Ian Cassel and the guests on this channel are not responsible for investment actions taken by viewers. Should you need such advice, consult a licensed financial advisor, legal advisor, or tax advisor. You agree to verify all information yourself before investing. Any past performance discussed during this program is no guarantee of future results. Investing involves risk and possible loss of principal capital; please seek advice from a licensed professional. All views expressed are personal opinions as of the date of recording and are subject to change without the responsibility to update views. No guarantee is given regarding the accuracy of the information on this channel. Releasees undertake no obligation to provide accurate or sound investment statements. You waive any and all duties that may exist flowing from you to any Releasee. You agree not to hold any Releasee liable for any possible claim for damages arising from any decision you make based on information or other content on the Channel.

This discussion took place live on April 23rd, 2026, on the MicroCapClub Community. Join MicroCapClub and unlock the ability to listen and participate live in these discussions - https://microcapclub.com/#join Pedro Sousa is a partner at Oxy Capital, a Portuguese investment firm based in Lisbon, where he leads the public markets strategy. He joined Oxy as an intern during his economics degree at Nova, spent two years at Bain in Spain, and returned to help build out the public book, which has grown from €20M of partner capital in December 2018 to over €100M today, compounding at roughly 20% net annualized.In this episode, Pedro explains how Oxy applies a private-equity approach to European small caps, five-year underwriting horizons, six-to-ten position concentration, and a sleeve of special situations covering spin-offs, asset-heavy liquidations, and partial M&A RemainCos. He walks through two current positions: The Gym Group, the UK's number two low-cost fitness chain, where he breaks down the local-monopoly unit economics of a single club; and Relais Group, the leading independent aftermarket player for commercial vehicles in the Nordics. He and David also discuss why European management teams get less inbound than US peers, how the team re-underwrites when a company misses expectations, and why Oxy hires undergraduates straight out of Portuguese universities✉️ Share your feedback - david@microcapclub.com✉️ David’s X (Twitter) - https://x.com/Valuehunte Chapters00:00 Introduction to Pedro Sousa and Oxy Capital04:15 Pedro's Journey into Investing07:07 Growth and Performance at Oxy Capital10:01 Investment Strategy: Private Equity Meets Public Markets12:58 Special Situations in Investing15:32 Team Dynamics and Investment Sourcing19:09 Market Dynamics: Public vs. Private Equity22:03 Case Studies: Successful Investments and Lessons Learned33:31 Understanding Gym Economics and Market Dynamics36:45 In-Depth Analysis of Relays Group46:54 Investment Re-Underwriting and Portfolio Management49:55 Recruitment Strategies and Talent Development54:09 Long-Term Investment Philosophy and Capital Management59:21 Future Aspirations and Closing ThoughtsDisclaimer: All content on this channel is for discussion, education, entertainment, and illustrative purposes only and SHOULD NOT be construed as professional financial advice, solicitation, or recommendation to buy or sell any securities, notwithstanding anything stated on this channel. There are risks associated with investing in securities. Loss of principal is possible. Past performance is not a predictor of future investment performance. Ian Cassel and the guests on this channel are not responsible for investment actions taken by viewers. Should you need such advice, consult a licensed financial advisor, legal advisor, or tax advisor. You agree to verify all information yourself before investing. Any past performance discussed during this program is no guarantee of future results. Investing involves risk and possible loss of principal capital; please seek advice from a licensed professional. All views expressed are personal opinions as of the date of recording and are subject to change without the responsibility to update views. No guarantee is given regarding the accuracy of the information on this channel. Releasees undertake no obligation to provide accurate or sound investment statements. You waive any and all duties that may exist flowing from you to any Releasee. You agree not to hold any Releasee liable for any possible claim for damages arising from any decision you make based on information or other content on the Channel.

In this Business Breakdown, David Barbato and Christian Schmidt sit down with Iridex’s (IRIX) CEO Patrick Mercer and CFO Romeo Dizon.This discussion took place live on February 27th, 2026, on the MicroCapClub Community. Join MicroCapClub and unlock the ability to listen and participate live in these discussions - https://microcapclub.com/join-now/This comprehensive interview with Patrick Mercer and Romeo Dizon of Iridex covers the company's strategic focus, financial turnaround, product portfolio, market opportunities, and future plans. Gain insights into how Iridex is positioning itself for growth in ophthalmic laser technology and the healthcare industry.✉️ Share your feedback - david@microcapclub.com✉️ David’s X (Twitter) - https://x.com/Valuehunte Chapters00:00 Introduction and Professional Backgrounds05:13 Business Performance and Financial Overview11:26 Retina Products and Market Opportunities14:23 Glaucoma Treatment Innovations and Market Potential19:51 Sales Strategy and Financial Health21:56 Q&A: Addressing Profitability Concerns26:24 Reimbursement Environment and Its Impact28:58 Socioeconomic Considerations in Glaucoma Treatment30:21 Drivers of Revenue Growth32:42 Future Acquisition Plans and Strategic Moves37:03 Understanding Cash Injection and Equity Alternatives37:45 Exploring the Relationship with Novel38:48 Competitive Landscape and Pricing Strategies40:43 Sales Force Efficiency and Company Strategy42:47 Evaluating Future Sales Force Expansion43:39 Operational Changes and Cost Management47:41 Headquarters Relocation and Employee Impact49:41 Prioritizing Cost Savings and Operational Efficiency52:45 CEO Adaptation and Investor Relations55:49 Future Outlook and Accountability MetricsDisclaimer: All content on this channel is for discussion, education, entertainment, and illustrative purposes only and SHOULD NOT be construed as professional financial advice, solicitation, or recommendation to buy or sell any securities, notwithstanding anything stated on this channel. There are risks associated with investing in securities. Loss of principal is possible. Past performance is not a predictor of future investment performance. Ian Cassel and the guests on this channel are not responsible for investment actions taken by viewers. Should you need such advice, consult a licensed financial advisor, legal advisor, or tax advisor. You agree to verify all information yourself before investing. Any past performance discussed during this program is no guarantee of future results. Investing involves risk and possible loss of principal capital; please seek advice from a licensed professional. All views expressed are personal opinions as of the date of recording and are subject to change without the responsibility to update views. No guarantee is given regarding the accuracy of the information on this channel. Releasees undertake no obligation to provide accurate or sound investment statements. You waive any and all duties that may exist flowing from you to any Releasee. You agree not to hold any Releasee liable for any possible claim for damages arising from any decision you make based on information or other content on the Channel.

In this Business Breakdown, David Barbato and Ian Cassel sit down with High Tide Inc’s (HITI) CEO Raj Grover and Capital Market Advisor Vahan Ajamian. The company was originally profiled by Ian Cassel on November 10, 2025, at $3.00 USD per share. This discussion took place live on February 17th, 2026, on the MicroCapClub Community. Join MicroCapClub and unlock the ability to listen and participate live in these discussions - https://microcapclub.com/join-now/In this conversation, Raj Grover, CEO of High Tide, discusses the company's journey from a single tobacco shop to the largest cannabis retailer in Canada. He shares insights into their innovative business model, including a unique loyalty program that has significantly boosted customer engagement and sales. The discussion also covers Hightide's expansion strategy, both domestically and internationally, as well as the challenges and opportunities within the cannabis market. Grover emphasizes the importance of location, store economics, and the company's commitment to becoming a global leader in cannabis retail.✉️ Share your feedback - david@microcapclub.com✉️ David’s X (Twitter) - https://x.com/Valuehunte Chapters00:00 Introduction to Hightide and Its Leaders04:31 Raj Grover's Entrepreneurial Journey07:06 Hightide's Business Model and Growth12:56 Loyalty Programs and Customer Engagement19:00 Market Share and Expansion Plans23:47 Financial Performance and Future Projections28:08 Challenges and Opportunities in the Cannabis Market34:21 Retail Expansion and Location Strategy40:27 Unit Economics and Store Performance45:34 Inorganic Growth and Acquisitions49:32 White Label Strategy and Product Differentiation54:24 European Market Expansion and Ramexion Acquisition01:01:47 Future Plans and U.S. Market StrategyDisclaimer: All content on this channel is for discussion, education, entertainment, and illustrative purposes only and SHOULD NOT be construed as professional financial advice, solicitation, or recommendation to buy or sell any securities, notwithstanding anything stated on this channel. There are risks associated with investing in securities. Loss of principal is possible. Past performance is not a predictor of future investment performance. Ian Cassel and the guests on this channel are not responsible for investment actions taken by viewers. Should you need such advice, consult a licensed financial advisor, legal advisor, or tax advisor. You agree to verify all information yourself before investing. Any past performance discussed during this program is no guarantee of future results. Investing involves risk and possible loss of principal capital; please seek advice from a licensed professional. All views expressed are personal opinions as of the date of recording and are subject to change without the responsibility to update views. No guarantee is given regarding the accuracy of the information on this channel. Releasees undertake no obligation to provide accurate or sound investment statements. You waive any and all duties that may exist flowing from you to any Releasee. You agree not to hold any Releasee liable for any possible claim for damages arising from any decision you make based on information or other content on the Channel.

Join MicroCapClub and unlock the ability to listen and participate live in these discussions - https://microcapclub.com/join-now/In this conversation, Michael Liu, founder of Capuchin Capital, shares his journey from early experiences in investing to establishing his own firm focused on microcap and biotech investments. He discusses his unique investment strategies, the importance of understanding shareholder dynamics, and the challenges of managing investor expectations. Michael also emphasizes the significance of mental clarity in trading, shares resources for researching small companies, and challenges conventional investing wisdom. Throughout the discussion, he provides insights into the volatility and opportunities present in the biotech sector, as well as practical advice for aspiring investors.✉️ Share your feedback - david@microcapclub.com✉️ David’s X (Twitter) - https://x.com/Valuehunte Chapters00:00 Introduction to Michael Liu and Capuchin Capital01:40 Michael Liu's Early Days in Investing06:04 Transitioning to Capuchin Capital10:24 Investment Strategies and Experiences15:24 Understanding Biotech Investment Dynamics18:36 Case Studies in Biotech Investments23:47 Navigating the Challenges of Fund Management33:22 Trading Biotech Stocks: Liquidity and Timing36:00 The Importance of a Clear Mind in Trading38:53 Daily Routines and Mental Balance for Traders40:36 Position Sizing and Risk Management Strategies44:30 Researching Small Companies: Resources and Techniques46:23 Advice for Aspiring Investors: Education and Passion51:00 Challenging Conventional Investing Wisdom54:59 Understanding Scale in Investing Strategies58:52 Utilizing Resources for Press Releases and NewsDisclaimer: All content on this channel is for discussion, education, entertainment, and illustrative purposes only and SHOULD NOT be construed as professional financial advice, solicitation, or recommendation to buy or sell any securities, notwithstanding anything stated on this channel. There are risks associated with investing in securities. Loss of principal is possible. Past performance is not a predictor of future investment performance. Ian Cassel and the guests on this channel are not responsible for investment actions taken by viewers. Should you need such advice, consult a licensed financial advisor, legal advisor, or tax advisor. You agree to verify all information yourself before investing. Any past performance discussed during this program is no guarantee of future results. Investing involves risk and possible loss of principal capital; please seek advice from a licensed professional. All views expressed are personal opinions as of the date of recording and are subject to change without the responsibility to update views. No guarantee is given regarding the accuracy of the information on this channel. Releasees undertake no obligation to provide accurate or sound investment statements. You waive any and all duties that may exist flowing from you to any Releasee. You agree not to hold any Releasee liable for any possible claim for damages arising from any decision you make based on information or other content on the Channel.